跳至主要内容
临床试验/CTRI/2023/03/050748
CTRI/2023/03/050748尚未招募2 期

A Study to Evaluate the Safety and Efficacy of Habb -e-Mujarrab in the Management of Migraine (Shaqiqa) without Aura: A Randomized single blind with standard control study

Central Council for Research in Unani Medicine New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Clinically diagnosed patient of Migraine without aura according to ICHD criteria.
  • 2)Patients in age group of 18 to 65 years.
  • 3)Irrespective of gender.
  • 4)Patients, who are ready to sign the informed consent, follow the protocol and willing to participate in clinical study voluntarily
  • 5)Willing to complete daily diary.

排除标准

  • 1)Patients below 18 years and above 65 years.
  • 2)Patient who fail to follow up.
  • 3)Patient who fail to give written consent. 4)Patient with known History Brain Tumors, Epilepsy, Stroke, Depression, Anxiety.
  • 5)Patients suffering from systemic illnesses like, Diabetes Mellitus, Uncontrolled Hypertension, Malignancy, Liver and Kidney dysfunction.
  • 6)Pregnant and lactating mother.

研究者

发起方
Central Council for Research in Unani Medicine New Delhi

相似试验